Next Article in Journal
Novel Tools towards Magnetic Guidance of Neurite Growth: (I) Guidance of Magnetic Nanoparticles into Neurite Extensions of Induced Human Neurons and In Vitro Functionalization with RAS Regulating Proteins
Previous Article in Journal
Strategies to Tune Electrospun Scaffold Porosity for Effective Cell Response in Tissue Engineering
Article Menu

Export Article

Open AccessReview

The Role of In Vitro Immune Response Assessment for Biomaterials

Department of Medicine, University of Auckland, Auckland 1142, New Zealand
*
Author to whom correspondence should be addressed.
J. Funct. Biomater. 2019, 10(3), 31; https://doi.org/10.3390/jfb10030031
Received: 26 April 2019 / Revised: 15 June 2019 / Accepted: 5 July 2019 / Published: 12 July 2019
  |  
PDF [849 KB, uploaded 12 July 2019]
  |     |  

Abstract

Grafts are required to restore tissue integrity and function. However, current gold standard autografting techniques yield limited harvest, with high rates of complication. In the search for viable substitutes, the number of biomaterials being developed and studied has increased rapidly. To date, low clinical uptake has accompanied inherently high failure rates, with immune rejection a specific and common end result. The objective of this review article was to evaluate published immune assays evaluating biomaterials, and to stress the value that incorporating immune assessment into evaluations carries. Immunogenicity assays have had three areas of focus: cell viability, maturation and activation, with the latter being the focus in the majority of the literature due to its relevance to functional outcomes. With recent studies suggesting poor correlation between current in vitro and in vivo testing of biomaterials, in vitro immune response assays may be more relevant and enhance ability in predicting acceptance prior to in vivo application. Uptake of in vitro immune response assessment will allow for substantial reductions in experimental time and resources, including unnecessary and unethical animal use, with a simultaneous decrease in inappropriate biomaterials reaching clinic. This improvement in bench to bedside safety is paramount to reduce patient harm. View Full-Text
Keywords: in vitro; immune response; immunogenicity; biomaterials; tissue regeneration in vitro; immune response; immunogenicity; biomaterials; tissue regeneration
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Lock, A.; Cornish, J.; Musson, D.S. The Role of In Vitro Immune Response Assessment for Biomaterials. J. Funct. Biomater. 2019, 10, 31.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Funct. Biomater. EISSN 2079-4983 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top